Authors: ZANDER AR BERGER C KROGER N SCHONROCK P KRUGER W STOCKSCHLADER M BIELING P KABISCH H FIEDLER W DEWIT M HUTTMANN A GRIMM J ERTTMANN R KUSE R

Citation: Ar. Zander et al., CONDITIONING WITH BUSULFAN, ETOPOSIDE (VP16) AND CYCLOPHOSPHAMIDE IN AML IN FIRST REMISSION, Experimental hematology, 25(8), 1997, pp. 480-480

Authors: HUTTMANN A HEIDT V BENDER D WORSDORFER E

Citation: A. Huttmann et al., CORE DESIGN FOR THE BOILING WATER-REACTOR SWR-1000, Kerntechnik, 61(5-6), 1996, pp. 228-231

Authors: MROSS K HUTTMANN A HERBST K HANAUSKE AR SCHILLING T MANEGOLD C BURK K HOSSFELD DK

Citation: K. Mross et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NEW PODOPHYLLOTOXIN DERIVATIVE NK-611 - A STUDY BY THE AIO-GROUPS PHASE-I AND APOH, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 217-224

Authors: HUTTMANN A MROSS K HOSSFELD DK

Citation: A. Huttmann et al., DETERMINATION OF THE NEW PODOPHYLLOTOXIN DERIVATIVE NK-611 IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography. Biomedical applications, 620(2), 1993, pp. 233-238